Introduction to Life Science Technology Commercialization Symposium

      Friday, June 1, 2012

Research Auditorium, Building 10, North Campus Research Complex, University of Michigan

     Symposium Agenda

8:30 am


9:00 am

Welcome and opening remarks

James Baker Jr., MD, Director, Michigan Nanotechnology Institute for Medicine and Biological Sciences

9:15 am

Session 1: To Commercialize or Not? – The Pros and Cons of Commercializing Life Science Technology

Tom Porter, MBA, Executive in Residence, Ross School of Business

10:00 am

Session 2: Paths for Successful Commercialization

Scott Olson, MBA, Managing Director, Medical Innovation Center

10:45 am


11:00 am

Session 3: Key Commercialization Questions

Jim Adox, MBA, Venture Investors

11:45 am


Location: South Atrium, Building 10, North Campus Research Complex

12:45 pm

Session 4: Intellectual Property and Working with the Office of Technology Transfer

Douglas Hockstad, Office of Technology Transfer

1:30 pm

Session 5: Drugs, Devices, Diagnostics – The Road to an Industry Partnership

Michael R. Bleavins, PhD, DABT, White Crow Innovation, LLC

2:15 pm


2:45 pm

Panel 1: Leveraging University & Community Resources for Success

Moderator: Connie Chang, MBA, Medical School Business Development


  • Unit for Laboratory Animal Medicine and UM CORE Facilities - Ingrid Bergin, VMD, MS
  • Academic Programs – Aileen Huang-Saad, PhD, MBA
  • Medical Innovation Center – Scott Olson, MBA
  • Office of Technology Transfer - Matt Bell, MBA
  • Ann Arbor SPARK –  Bill Mayer

3:45 pm

Panel 2: Successes in Translating University Technology

Moderator: Aileen Huang-Saad, PhD, MBA, Center for Entrepreneurship


  • James Baker Jr., MD – NanoBio
  • Gary Glick, PhD – Lycera
  • Kalyan Handique, PhD – HandyLab
  • James Shayman, MD – Genzyme
  • Tom Porter, MBA – IntraLase

4:45 pm

Closing Remarks

5:00 pm


Location: South Atrium, Building 10, North Campus Research Complex